Update date: 08/01/2026

Board of Trustees
Management Committee
Scientific Direction
Executive Management
External Scientific Committee
Investigation Commission
Internal Scientific Committee
research faculty

Governing and management bodies

Board of Trustees

Ángel Sanz Barea
Councilor of the Government of Aragon with powers in health (President)

Rosa María Bolea Dance
Rector of UNIZAR (Vice President)

Alfonso Peña Ochoa
UNIZAR Manager

José Ignacio Castaño Lasaosa
Managing Director of HEALTH

Elena Gonzalvo Suñer
Managing Director of IACS

Pilar Pina Iritia
Appointed by the Rector of UNIZAR
(Vice-Rector for Scientific Policy)

Manuel González Bedia
Appointed by the Rector of UNIZAR (Vice-Rector for Innovation, Transfer and Continuing Education)

Gerardo Rodríguez Martínez
Appointed by the Rector of UNIZAR (Advisor to the Rector for Health Sciences)

Patricia Palazón Saura
Appointed by the Managing Director of HEALTH
(Manager of Sector II of Zaragoza)
Zoraida Soriano Gil
Appointed by the Managing Director of the IACS
Director of the Production and Innovation Area of ​​the IACS

Management Committee

Daniel Oros Lopez
Scientific Director IIS Aragón

Pilar Pina Iritia
Vice-rector for Scientific Policy (UNIZAR)

Elena Gonzalvo Suñer
Managing Director of IACS
Patricia Palazón Saura
Manager of the Miguel Servet University Hospital

Alfonso Peña Ochoa
UNIZAR Manager

Oscar Lopez Lorente
Executive Director IIS Aragón

Scientific Direction

 

Daniel Oros Lopez
Scientific Director

Biography
Dr. Daniel Orós López is a Professor of Obstetrics and Gynecology at the Faculty of Medicine of the University of Zaragoza, a Specialist Physician in the Maternal-Fetal Medicine Unit of the Lozano Blesa University Clinical Hospital and Principal Investigator of the consolidated group of excellence “Placental Pathophysiology and Fetal Programming” of the Aragon Health Research Institute.

He holds a degree in Medicine from the University of Zaragoza, is a specialist in Obstetrics and Gynecology from the University Clinical Hospital of Zaragoza, and has a PhD in Medicine from the University of Barcelona. He completed advanced training as a specialist in Maternal-Fetal Medicine at the Hospital Clínic of Barcelona–IDIBAPS (2006-2007) and obtained a Master's degree in Research Methodology in Health Sciences from the Autonomous University of Barcelona.

Dr. Oros has been a Visiting Research Fellow at the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford since 2016, with extended stays funded by competitive programs from the ISCIII (Carlos III Health Institute). He has also completed research stays at Thomas Jefferson Hospital (Philadelphia, USA), Aberdeen Royal Infirmary (UK), and other leading centers of excellence in Spain. Between 2016 and 2018, he was selected for the international GLOBE (Global Leadership & Organizational Behavior Effectiveness) program, which focuses on training emerging scientific leaders in Obstetrics worldwide.

Her career encompasses clinical practice, translational research, and scientific management, with experience leading established research groups, training researchers, and securing sustained competitive funding. She has spearheaded the development of research talent through national human resources programs, including Río Hortega, PFIS, and Juan Rodés contracts from the Carlos III Health Institute, and is a regular participant in scientific evaluation processes and academic and societal governance bodies. Institutionally, she has served on the Board of Directors of the Spanish Society of Gynecology and Obstetrics (Perinatal Medicine Section, 2012–2022) and the Aragonese Association of Gynecology and Obstetrics (2018–2022). She has received awards for best scientific communication and is a frequent speaker at national and international scientific forums on maternal-fetal medicine.

His scientific output includes 63 indexed articles, with 75% published in first quartile journals and 68% in first decile journals, achieving an H-index of 22 (January 2026).

In the field of publishing and scientific evaluation, he has been Associate Editor of the British Journal of Obstetrics and Gynaecology and a member of the editorial boards of PLOS One, Maternal Health, Neonatology and Perinatology, and Clinical and Research in Gynecology and Obstetrics. He also participates as an expert evaluator for the National R&D Plan.

ResearcherID: C-1788-2014
https://orcid.org/0000-0002-8476-9161
www.linkedin.com/in/daniel-oros

Dr. Yolanda Gilaberte Calzada
Clinical Scientific Subdirector

Dr. Patricia Sancho Andrés
Deputy Director of Preclinical Science

Biography
Dr. Yolanda Gilaberte is a specialist in Dermatology and has been Head of the Dermatology Department at the Miguel Servet University Hospital in Zaragoza since 2017. She is also the principal investigator of the InnDerma Miguel Servet Consolidated Research Group of the IIS Aragón and of the Government of Aragón's consolidated group "Dermatology and Photobiology" since 2013.

A graduate in Medicine and Surgery in 1989, she completed her specialized training via MIR in Dermatology in 1993. She obtained a predoctoral FPU grant from the Ministry of Education and Science and earned her doctorate in Medicine in 1995 with the highest distinction, summa cum laude. She completed her research training with stays at Johns Hopkins Hospital in Baltimore and Massachusetts General Hospital in Boston, where she worked as a Research Fellow.

Her scientific career has focused on clinical dermatology, photobiology, and skin cancer prevention. She has coordinated the "SolSano" skin cancer prevention program for the Government of Aragon and has participated as principal investigator and collaborator in numerous competitive projects funded by the Carlos III Health Institute and other national funding programs. She currently leads several FIS projects and an independent clinical trial.

She has a distinguished scientific output, with 313 publications indexed in PubMed, an H-index of 33, and two recognized six-year research periods. She has supervised 13 doctoral theses and participated as principal investigator or collaborator in more than 45 clinical trials and observational studies. Her innovative work includes a patent, intellectual property, and the development of an application for the design of personalized medicines.

Among her accolades are three awards from the Spanish Academy of Dermatology and Venereology (AEDV), the 2014 Hinnovara Award, the 2021 ENovaHealth Award, and two International Citations from the American Academy of Dermatology (2024 and 2026). She was also included in Forbes' list of the 100 best doctors in Spain in 2022, 2024, and 2025.

She has been actively involved in scientific and institutional leadership, chairing various hospital research and innovation bodies and serving on numerous regional and hospital committees. Within the scientific community, she was Vice President of the AEDV (2018-2022) and President from 2022 to 2026, later becoming Honorary President and Director of its Foundation. She has also held positions of responsibility in the European Academy of Dermatology and Venereology and other international scientific societies.

She combines her clinical and research activities with extensive teaching and publishing work. She is currently a tenured lecturer with clinical ties to Dermatology at the University of Zaragoza and has served as an editorial advisor for leading national and international scientific journals. In addition, she regularly participates as an expert evaluator in competitive research grant programs at the Carlos III Health Institute.
Biography
Dr. Patricia Sancho is the principal investigator of the consolidated group GIIS107 Metabolism and Tumor Stem Cells at the Aragon Health Research Institute since joining as a Miguel Servet researcher in March 2017.

She holds a degree in Molecular and Cellular Biology from the University of Alcalá and a PhD in Cell Biology from the same university, after completing her doctoral thesis at the Margarita Salas Center for Biological Research (CIB, CSIC; Madrid). She has undertaken several postdoctoral fellowships at the Pasteur Institute (Paris, France; 2005), the Bellvitge Biomedical Research Institute (Barcelona; 2006-2012), and the Spanish National Cancer Research Centre (Madrid; 2012-2014). Subsequently, she was recruited by the Barts Cancer Institute (London, UK; 2014-2016) as an associate professor at Queen Mary University of London and principal investigator of the Stem Cells in Cancer and Ageing unit.

She has had a distinguished career in cancer research, particularly in the field of tumor metabolism. Her scientific output includes 58 indexed articles, most with above-average citation rates, achieving an H-index of 40 (May 2026). She has secured competitive funding for projects at the national and international levels (Pancreatic Cancer Fund, Worldwide Cancer Research, AECC, Health Research Fund, La Caixa Health Research, Aspanoa, among others), as well as for human resources. In 2021, she received the National Young Researchers Award from the Caja Rural Soria Scientific Foundation, and in 2026, the Woman Aragón Award for research talent (Prensa Ibérica group).

Since 2023, she has been a member of the Board of Directors of the Spanish Association for Cancer Research (ASEICA), where she coordinates the ASEICA Women and ASEICA Young working groups. Since 2022, she has coordinated ASEICA's "Get to Know Them" initiative to raise the profile of female researchers, receiving the "Promoting Scientific Vocations" award in collaboration with the Merck Health Foundation (2022, 2023) and Johnson & Johnson (2024).

In addition, she regularly participates as an expert evaluator in human resources and funding programs of AECC, the National R&D Plan and in the evaluation coordination of the Carlos III Health Institute.

Scientific Direction

Daniel Oros Lopez
Scientific Director

Biography
Dr. Daniel Orós López is a Professor of Obstetrics and Gynecology at the Faculty of Medicine of the University of Zaragoza, a Specialist Physician in the Maternal-Fetal Medicine Unit of the Lozano Blesa University Clinical Hospital and Principal Investigator of the consolidated group of excellence “Placental Pathophysiology and Fetal Programming” of the Aragon Health Research Institute.

He holds a degree in Medicine from the University of Zaragoza, is a specialist in Obstetrics and Gynecology from the University Clinical Hospital of Zaragoza, and has a PhD in Medicine from the University of Barcelona. He completed advanced training as a specialist in Maternal-Fetal Medicine at the Hospital Clínic of Barcelona–IDIBAPS (2006-2007) and obtained a Master's degree in Research Methodology in Health Sciences from the Autonomous University of Barcelona.

Dr. Oros has been a Visiting Research Fellow at the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford since 2016, with extended stays funded by competitive programs from the ISCIII (Carlos III Health Institute). He has also completed research stays at Thomas Jefferson Hospital (Philadelphia, USA), Aberdeen Royal Infirmary (UK), and other leading centers of excellence in Spain. Between 2016 and 2018, he was selected for the international GLOBE (Global Leadership & Organizational Behavior Effectiveness) program, which focuses on training emerging scientific leaders in Obstetrics worldwide.

Her career encompasses clinical practice, translational research, and scientific management, with experience leading established research groups, training researchers, and securing sustained competitive funding. She has spearheaded the development of research talent through national human resources programs, including Río Hortega, PFIS, and Juan Rodés contracts from the Carlos III Health Institute, and is a regular participant in scientific evaluation processes and academic and societal governance bodies. Institutionally, she has served on the Board of Directors of the Spanish Society of Gynecology and Obstetrics (Perinatal Medicine Section, 2012–2022) and the Aragonese Association of Gynecology and Obstetrics (2018–2022). She has received awards for best scientific communication and is a frequent speaker at national and international scientific forums on maternal-fetal medicine.

His scientific output includes 63 indexed articles, with 75% published in first quartile journals and 68% in first decile journals, achieving an H-index of 22 (January 2026).

In the field of publishing and scientific evaluation, he has been Associate Editor of the British Journal of Obstetrics and Gynaecology and a member of the editorial boards of PLOS One, Maternal Health, Neonatology and Perinatology, and Clinical and Research in Gynecology and Obstetrics. He also participates as an expert evaluator for the National R&D Plan.

ResearcherID: C-1788-2014
https://orcid.org/0000-0002-8476-9161
www.linkedin.com/in/daniel-oros

Dr. Yolanda Gilaberte Calzada
Clinical Scientific Subdirector

Dr. Patricia Sancho Andrés
Deputy Director of Preclinical Science

Biography
Dr. Yolanda Gilaberte is a specialist in Dermatology and has been Head of the Dermatology Department at the Miguel Servet University Hospital in Zaragoza since 2017. She is also the principal investigator of the InnDerma Miguel Servet Consolidated Research Group of the IIS Aragón and of the Government of Aragón's consolidated group "Dermatology and Photobiology" since 2013.

A graduate in Medicine and Surgery in 1989, she completed her specialized training via MIR in Dermatology in 1993. She obtained a predoctoral FPU grant from the Ministry of Education and Science and earned her doctorate in Medicine in 1995 with the highest distinction, summa cum laude. She completed her research training with stays at Johns Hopkins Hospital in Baltimore and Massachusetts General Hospital in Boston, where she worked as a Research Fellow.

Her scientific career has focused on clinical dermatology, photobiology, and skin cancer prevention. She has coordinated the "SolSano" skin cancer prevention program for the Government of Aragon and has participated as principal investigator and collaborator in numerous competitive projects funded by the Carlos III Health Institute and other national funding programs. She currently leads several FIS projects and an independent clinical trial.

She has a distinguished scientific output, with 313 publications indexed in PubMed, an H-index of 33, and two recognized six-year research periods. She has supervised 13 doctoral theses and participated as principal investigator or collaborator in more than 45 clinical trials and observational studies. Her innovative work includes a patent, intellectual property, and the development of an application for the design of personalized medicines.

Among her accolades are three awards from the Spanish Academy of Dermatology and Venereology (AEDV), the 2014 Hinnovara Award, the 2021 ENovaHealth Award, and two International Citations from the American Academy of Dermatology (2024 and 2026). She was also included in Forbes' list of the 100 best doctors in Spain in 2022, 2024, and 2025.

She has been actively involved in scientific and institutional leadership, chairing various hospital research and innovation bodies and serving on numerous regional and hospital committees. Within the scientific community, she was Vice President of the AEDV (2018-2022) and President from 2022 to 2026, later becoming Honorary President and Director of its Foundation. She has also held positions of responsibility in the European Academy of Dermatology and Venereology and other international scientific societies.

She combines her clinical and research activities with extensive teaching and publishing work. She is currently a tenured lecturer with clinical ties to Dermatology at the University of Zaragoza and has served as an editorial advisor for leading national and international scientific journals. In addition, she regularly participates as an expert evaluator in competitive research grant programs at the Carlos III Health Institute.
Biography
Dr. Patricia Sancho is the principal investigator of the consolidated group GIIS107 Metabolism and Tumor Stem Cells at the Aragon Health Research Institute since joining as a Miguel Servet researcher in March 2017.

She holds a degree in Molecular and Cellular Biology from the University of Alcalá and a PhD in Cell Biology from the same university, after completing her doctoral thesis at the Margarita Salas Center for Biological Research (CIB, CSIC; Madrid). She has undertaken several postdoctoral fellowships at the Pasteur Institute (Paris, France; 2005), the Bellvitge Biomedical Research Institute (Barcelona; 2006-2012), and the Spanish National Cancer Research Centre (Madrid; 2012-2014). Subsequently, she was recruited by the Barts Cancer Institute (London, UK; 2014-2016) as an associate professor at Queen Mary University of London and principal investigator of the Stem Cells in Cancer and Ageing unit.

She has had a distinguished career in cancer research, particularly in the field of tumor metabolism. Her scientific output includes 58 indexed articles, most with above-average citation rates, achieving an H-index of 40 (May 2026). She has secured competitive funding for projects at the national and international levels (Pancreatic Cancer Fund, Worldwide Cancer Research, AECC, Health Research Fund, La Caixa Health Research, Aspanoa, among others), as well as for human resources. In 2021, she received the National Young Researchers Award from the Caja Rural Soria Scientific Foundation, and in 2026, the Woman Aragón Award for research talent (Prensa Ibérica group).

Since 2023, she has been a member of the Board of Directors of the Spanish Association for Cancer Research (ASEICA), where she coordinates the ASEICA Women and ASEICA Young working groups. Since 2022, she has coordinated ASEICA's "Get to Know Them" initiative to raise the profile of female researchers, receiving the "Promoting Scientific Vocations" award in collaboration with the Merck Health Foundation (2022, 2023) and Johnson & Johnson (2024).

In addition, she regularly participates as an expert evaluator in human resources and funding programs of AECC, the National R&D Plan and in the evaluation coordination of the Carlos III Health Institute.

Executive Management

 
Oscar Lopez Lorente
Executive Director

Advisory Bodies

External Scientific Committee

Mary Abbot
Principal Investigator at Altos Labs

Ana Cuenda
Deputy Director of the National Center for Biotechnology (CNB-CSIC)

Full Professor. CSIC at the CNB-CSIC

Eduard Gratacós
Director of BCNatal (Hospital Clínic + Hospital Sant Joan de Déu Barcelona)

Professor of Obstetrics and Gynecology. University of Barcelona

Director of the BCNatal Fetal Medicine Research Center

Pablo Lamata
Professor in Computational Cardiology, King's College London

Director of the Center for Doctoral Training in Digital Twins for Healthcare (DT4Health CDT), King's College London

Laura Lettuce
Research Professor at the CSIC in the Catalan Institute of Nanoscience and Nanotechnology (ICN2)

 

Investigation Commission

Daniel Oros Lopez
President

Isabel Pinilla Lozano
Member
Asuncion Garcia Gonzalez
Member
Antonio Anton Torres
Member
José María Marín Trigo
Member
María José Rabanaque Hernández
Member
Ana Cenarro Laguna
Member
Jesus Osada Garcia
Member
Javier Naval Iraberri
Member
Elena Altarribas Bag
Member
Fernando Civeira Murillo
Member
José Manuel Ramírez Rodríguez
Member
Jon Schoorlemmer
Member
José Ignacio Labarta Aizpún
Member
José Ramón Paño Pardo
Member
Luis Moreno Aznar
Member

Juan Pablo Martinez
Member

Sergio Cervero Benedí
Secretary

Participation Bodies

Internal Scientific Committee

Daniel Oros Lopez
Scientific Director of the IIS Aragon

Yolanda Gilaberte Calzada
Clinical Scientific Subdirector

Patricia Sancho Andrés
Deputy Director of Preclinical Science

Oscar Lopez Lorente
Executive Director of IIS Aragon

Jorge Rubio Gracia
Coordinator of the Cardiovascular, Metabolism and Nutrition Program

Ana Mincholé Lapuente
Coordinator of the Biomedical Engineering and Data Science Program

Rosario Osta Pinzolas
Neuroscience, Mental Health and Sense Organs Program Coordinator

Alberto Jimenez Schuhmacher
Coordinator of the Immunity, Cancer and Infectious Diseases Program

Isabel Aguilar Palacio
Primary Care, Nursing and Health Care Program Coordinator

Diego Sanchez Martinez
Coordinator of the Cross-Cutting Program for Advanced Therapies

Pablo Herrero Gallego
Representative of Emerging and Associated Groups

Cristina Paules Tejero
R3 Research Representative - Clinical

Pending
R3 Research Representative - Basic

Pending
Representative of Researchers R2

Natalia Victoria Izquierdo Brusau
Representative of Researchers in Training

Eva Lopez Hernandez
Representative in the field of translation

Sergio Cervero Benedí
Representative in the field of research

Javier Aragón Fernández
Secretary of the Internal Scientific Committee

 
 

research faculty

 
It is a participation body made up of the main researchers from all the groups integrated into the institute, and chaired by the Scientific Director.